Pharming Group Stock Forecast - Market Facilitation Index
| PHARM Stock | EUR 0.87 0.01 1.14% |
Pharming Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pharming Group stock prices and determine the direction of Pharming Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pharming Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
Pharming |
| Check Pharming Group Volatility | Backtest Pharming Group | Trend Details |
Pharming Group Trading Date Momentum
| On December 06 2024 Pharming Group NV was traded for 0.74 at the closing time. The highest price during the trading period was 0.74 and the lowest recorded bid was listed for 0.72 . The volume for the day was 5 M. This history from December 6, 2024 contributed to the next trading day price jump. The trading delta at closing time to the next closing price was 2.78% . The trading delta at closing time to the current price is 13.89% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Pharming Group to competition |
Other Forecasting Options for Pharming Group
For every potential investor in Pharming, whether a beginner or expert, Pharming Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharming Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharming. Basic forecasting techniques help filter out the noise by identifying Pharming Group's price trends.Pharming Group Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharming Group stock to make a market-neutral strategy. Peer analysis of Pharming Group could also be used in its relative valuation, which is a method of valuing Pharming Group by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pharming Group NV Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pharming Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pharming Group's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Pharming Group Market Strength Events
Market strength indicators help investors to evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By undertsting and applying Pharming Group stock market strength indicators, traders can identify Pharming Group NV entry and exit signals to maximize returns.
Pharming Group Risk Indicators
The analysis of Pharming Group's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharming stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.52 | |||
| Semi Deviation | 2.58 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.77 | |||
| Downside Variance | 12.04 | |||
| Semi Variance | 6.68 | |||
| Expected Short fall | (3.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Information and Resources on Investing in Pharming Stock
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Pharming Group to cross-verify your projections. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.